Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06XPL
|
|||
| Former ID |
DIB007769
|
|||
| Drug Name |
TOCA-511
|
|||
| Synonyms |
Combination vector-delivered gene therapy/5-flurocytosine (5-FC) prodrug (glioblastoma multiforme), Tocagen
Click to Show/Hide
|
|||
| Indication | Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 2/3 | [1] | |
| Company |
Tocagen Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02414165) P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.